With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|PRL3 as a Novel Therapeutic Target for Relapsed T-cell Acute Lymphoblastic Leukemia||Massachusetts General Hospital / Jessica Blackburn, PhD||Young Investigator Grants||2013||Massachusetts|
|An Oncolytic Herpes Simplex Virus Restricted in Entry to Neuroblastoma Cells||Northwestern University Medical School / Richard Longnecker, PhD||Innovation Grants||2013||Illinois|
|Theranostics in Children and Young Adults||University of Iowa / Sue O'Dorisio, MD, PhD||Springboard Grants||2013||Iowa|
|IDO-based Immunotherapy for Pediatric Brain Tumors||Georgia Health Sciences University Research Institute, Inc. / Theodore Johnson, MD, PhD||'A' Award Grants||2013||Georgia|
|LRP1 and Angiogenesis in Pediatric Malignant Glioma||Mayo Clinic Jacksonville / Takahisa Kanekiyo, MD, PhD||Young Investigator Grants||2013||Florida|
|Children's Hospital Colorado Experimental Therapeutics Program||Children's Hospital Colorado / Lia Gore, MD||Phase I/II Infrastructure Grants||2013||Colorado|
|Development of a Novel Mer Tyrosine Kinase Inhibitor for Treatment of ALL||University of Colorado Denver / Doug Graham, MD, PhD||Reach Grants||2013||Colorado|
|Characterization of the Role of Chromosome 1p Deletion in MYCN-Amplified Neuroblastoma||University of California San Francisco / Miller Huang, PhD||Young Investigator Grants||2013||California|
|Develop a Therapeutic Vaccine Approach by Removing Viral Immune Evasion||University of California, Los Angeles / Ren Sun, PhD||Springboard Grants||2013||California|
|Neural Stem Cell-Mediated Drug Delivery for Targeted Treatment of Medulloblastoma||Beckman Research Institute of City of Hope / Margarita Gutova, MD||Reach Grants||2013||California|